688076.SHG Sinopep-Allsino Biopharmaceutical Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
26.88 CNY
Close of Nov 4, 2026
25.70 40.64
Market cap
CNY 8.50B
P/E
37.3x
P/B
2.58x
ROE
13.9%
Dividend yield
2.82%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688076.SHG undervalued?

Graham number
Price26.88
Graham value12.99
Premium106.9%

688076.SHG trades 106.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sinopep-Allsino Biopharmaceutical Co. Ltd. A fundamental analysis

No fundamental analysis for Sinopep-Allsino Biopharmaceutical Co. Ltd. A yet.

Sinopep-Allsino Biopharmaceutical Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sinopep-Allsino Biopharmaceutical Co. Ltd. A

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers custom peptide synthesis, custom oligo synthesis, conjugate synthesis, FTE, GMP peptides, oligonucleotide NCEs, generic APIs, formulation services, quotation request, research peptide quote, GMP peptide quote, oligonucleotide quote services. The company was…

Full company profile